Enhancements
HELP
PEOPLE
CENTERS
COMMUNITIES
RESEARCH STORIES
Expertise Finder Search
R01: TARGETING NADPH OXIDASE FOR PANCREATIC CANCER PREVENTION AND THERAPY
R01: TARGETING NADPH OXIDASE FOR PANCREATIC CANCER PREVENTION AND THERAPY
PI: Weiqin Lu
Sponsor: NIH - NATIONAL CANCER INSTITUTE
Pharmaceutical Sciences
Amount awarded: $1,032,327
This project determines whether NADPH oxidase is a critical mediator for identifying pancreatic cancer.
Posting date:
Mon, 02/13/2023
Award start date:
Sat, 10/01/2022
Award end date:
Wed, 04/30/2025